• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C

    Authors

    • Asmaa K Ahmed 1
    • Shereen G Samy 2
    • Asmaa A Mohammed 3
    • Alshymaa A. Hassnine 4
    • M. Elsayed 4
    • Maysa A. Arandaz 1

    1 Internal medicin department-Faculty of medicine-Minia University, Egypt

    2 Biochemistry departement - Faculty of medicine-Minia University, Egypt

    3 One day surgery hospital - Ministry of health, Minia governerat, Egypt

    4 Department of Tropical Medicine, Faculty of medicine, Minia University, Minia, Egypt

,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background sustained virological response (SVR) can be achieved in high percentage of HCV patients with the availability of direct acting antiviral agents DAAs. However, the effect of DAAs on insulin resistance and glycemic control has to be clearly documented in patients with HCV infection and type 2diabtes mellitus.
We hypothesize that treatment of HCV with novel direct-acting antiviral medications may have effect on glycemic control and decreased requirement for DM-modulating medications at the time of SVR.
Patients and methods: the present study involved 50 patients with Chronic HCV attended to outpatient hepatology clinic of One Day Surgery Hospital for treatment with DAAs. Measurement of HbA1c, FPG, fasting insulin hormone, c-peptide and calculation of HOMA-IR before and 3 months after DDAs therapy is done.
Statistical analysis was done for these data. Results : After achievement of SVR; HbA1c decreased from 9.57±1.39 to 7.22 ± 0.7 in diabetic patients, HOMA-IR decreased significantly also there was a significant improvement of lipid profile after completion of therapy.
Conclusion: This study showed that eradication of HCV by DAAs cause a parallel decrease in IR and improve glycemic control in patients with established T2DM.

Keywords

  • HCV hepatitis c virus
  • DAA direct acting antivirus
  • DM diabetes mellitus
  • XML
  • PDF 327.04 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 190
    • PDF Download: 293
European Journal of Molecular & Clinical Medicine
Volume 7, Issue 10
December 2020
Page 1426-1435
Files
  • XML
  • PDF 327.04 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 190
  • PDF Download: 293

APA

Ahmed, A. K., Samy, S. G., Mohammed, A. A., Hassnine, A. A., Elsayed, M., & Arandaz, M. A. (2021). Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C. European Journal of Molecular & Clinical Medicine, 7(10), 1426-1435.

MLA

Asmaa K Ahmed; Shereen G Samy; Asmaa A Mohammed; Alshymaa A. Hassnine; M. Elsayed; Maysa A. Arandaz. "Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C". European Journal of Molecular & Clinical Medicine, 7, 10, 2021, 1426-1435.

HARVARD

Ahmed, A. K., Samy, S. G., Mohammed, A. A., Hassnine, A. A., Elsayed, M., Arandaz, M. A. (2021). 'Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C', European Journal of Molecular & Clinical Medicine, 7(10), pp. 1426-1435.

VANCOUVER

Ahmed, A. K., Samy, S. G., Mohammed, A. A., Hassnine, A. A., Elsayed, M., Arandaz, M. A. Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C. European Journal of Molecular & Clinical Medicine, 2021; 7(10): 1426-1435.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus